RxDoctor Payments Data

Bruce Durell, MD

Family Medicine · Plainfield, INNPI 1427092212

Payments from drug & device makers

$1,492in general payments, 2019–2025

Across 108 payments — averaging $13.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$213
  • Novo Nordisk$177
  • Novartis$167
  • Lilly USA, LLC$124
  • Amgen$122
  • Supernus Pharmaceuticals, Inc.$112
  • plus $576 from 14 others

What the payments were for

  • Food & beverage$1,492100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,492 in reported general payments places this provider in the 65th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$43,493
Medicare patients
161
Services billed
923

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban16$23,742
OzempicSemaglutide13$21,228
JardianceEmpagliflozin16$20,085
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$19,904
EliquisApixaban11$14,913
Fluticasone-SalmeterolFluticasone Propion/Salmeterol22$3,704
Arnuity ElliptaFluticasone Furoate11$3,127
Omeprazole185$2,657
Sumatriptan Succinate11$2,546
Atorvastatin Calcium317$2,431
Gabapentin105$2,025
Levothyroxine Sodium229$1,882
Esomeprazole Magnesium37$1,449
Pantoprazole Sodium108$1,255
Celecoxib20$1,230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Arnuity Ellipta$213$23,03131 claims
Novo NordiskOzempic$177$21,22813 claims
Boehringer IngelheimJardiance$24$20,08516 claims
PfizerEliquis$103$14,91311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Plainfield

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →